ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,320.76
0.43%
Dow Jones
42,441.31
0.63%
Gold vs US Dollar
2,648.675
-0.89%
Brent Oil
71.575
0.88%
Bitcoin
66,012.44
1.27%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amryt Pharma PLC (AMYT)

  7. Amryt Pharma PLC (AMYT) News

Amryt Pharma (AMYT)

Amryt Pharma PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AMYT
DateTimeSourceHeadlineSymbolCompany
18/04/202322:02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AMYTAmryt Pharma PLC
18/04/202322:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AMYTAmryt Pharma PLC
18/04/202321:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
12/04/202322:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
12/04/202313:21Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AMYTAmryt Pharma PLC
12/04/202312:58PR Newswire (US)Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma PlcNASDAQ:AMYTAmryt Pharma PLC
12/04/202312:00GlobeNewswire Inc.Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma PlcNASDAQ:AMYTAmryt Pharma PLC
11/04/202314:00GlobeNewswire Inc.2022 for Chiesi: The Group’s international growth continuesNASDAQ:AMYTAmryt Pharma PLC
03/04/202314:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
23/03/202313:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
16/02/202312:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
13/02/202315:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
10/02/202321:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
10/02/202314:49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
09/01/202321:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
07/11/202203:35TipRanksSVB Securities Keeps Their Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
04/11/202218:55TipRanksAmryt Pharma (AMYT) Receives a Buy from Maxim GroupNASDAQ:AMYTAmryt Pharma PLC
04/11/202210:25TipRanksAmryt Pharma (AMYT) Receives a Buy from H.C. WainwrightNASDAQ:AMYTAmryt Pharma PLC
03/11/202211:45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
19/09/202211:25TipRanksH.C. Wainwright Sticks to Its Buy Rating for Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
08/08/202213:27TipRanksH.C. Wainwright Keeps Their Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
05/08/202218:25TipRanksMaxim Group Reiterates a Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
14/07/202212:49Dow Jones NewsAmryt Gets FDA Orphan Designation for Mycapssa in Carcinoid SyndromeNASDAQ:AMYTAmryt Pharma PLC
26/06/202208:39TipRanksSVB Securities Keeps a Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
24/06/202212:54Dow Jones NewsAmryt to Pursue Formal FDA Resolution for Oleogel-S10NASDAQ:AMYTAmryt Pharma PLC
24/06/202212:19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
23/06/202212:26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
23/05/202211:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AMYTAmryt Pharma PLC
20/05/202222:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AMYTAmryt Pharma PLC
20/05/202221:59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AMYTAmryt Pharma PLC
 Showing the most relevant articles for your search:NASDAQ:AMYT

Your Recent History

USOTC
BUHPF
Bumrungrad Hospital (PK)
GATE
HSRETH
Hcash
AMEX
BLUA
BlueRiver Acquisition
NYSE
STXD
Strive 1000 Dividend Gro...
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
LSE
BE11
Nationwde. 37
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved